Concord Medical Services Holding Ltd. ADR Stock

$4.98

1.63% today

NYSE, Aug 12, 03:52 pm CET

ISIN

US2062771058

Symbol

CCM

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Overview Dividends Analysts Charts News Strategies

Concord Medical Services Holding Ltd. ADR Stock price

$4.90

-12.90 72.47% 5Y

NYSE, Closing price Mon, Aug 11 2025

-0.20 3.92%

ISIN

US2062771058

Symbol

CCM

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Key metrics

Basic

Market capitalization

$22.1m

Enterprise Value

$491.7m

Net debt

$469.5m

Cash

$48.8m

Shares outstanding

130.0m

Valuation (TTM | estimate)

P/E

negative | -

P/S

0.4 | -

EV/Sales

9.2 | -

EV/FCF

P/B

negative

Dividends

DPS

$0.00

Yield 1Y | 5Y

0.0% | 0.0%

Growth 1Y | 5Y

- | -

Payout 1Y | 3Y

0.0% | 0.0%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$53.4m | -

EBITDA

- | -

EBIT

$-74.1m | -

Net Income

$-42.9m | -

Free Cash Flow

Growth (TTM | estimate)

Revenue

-28.6% | -

EBITDA

- | -

EBIT

-14.9% | -

Net Income

-3.4% | -

Free Cash Flow

Financial Health

Equity Ratio

-33.9%

Return on Equity

13.5%

ROCE

-11.6%

ROIC

-8.4%

Debt/Equity

-1.6

EPS

$-0.3

FCF per Share

Short interest

0.1%

Employees

595

Rev per Employee

$90.0k

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Get Started for Free Today

Concord Medical Services Holding Ltd. ADR Stock Analysis

Unlock Scores for Free

??

8 Analysts have issued a Concord Medical Services Holding Ltd. ADR forecast:

2x Hold

25%

6x Sell

75%

More details on Analyst Estimates Including Price Targets

8 Analysts have issued a Concord Medical Services Holding Ltd. ADR forecast:

Hold

25%

Sell

75%

Analyst Estimates with Stock Price Targets

Financial data from Concord Medical Services Holding Ltd. ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	53 53	29% 29% 100%
- Direct Costs	64 64	25% 25% 121%
Gross Profit	-11 -11	3% 3% -21%
- Selling and Administrative Expenses	63 63	17% 17% 118%
- Research and Development Expense	- -	- -
EBITDA	- -	- -
- Depreciation and Amortization	- -	- -
EBIT (Operating Income) EBIT	-74 -74	15% 15% -139%
Net Profit	-43 -43	3% 3% -80%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Concord Medical Services Holding Ltd. ADR Stock News

Neutral

PRNewsWire

●

29 days ago

Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

BEIJING , July 14, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK, announced that on July 11, 2025, Guangzhou Concord Cancer Center, a subsidiary o...

Neutral

PRNewsWire

●

2 months ago

Concord Healthcare Announces Official Release of the Proton Therapy Large Model

BEIJING , May 29, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK, announced that Concord Healthcare had made important progress in precise tumor di...

Neutral

PRNewsWire

●

4 months ago

Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

BEIJING , April 25, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "Annual Report") with the U.S. Securities and Exchange...

Company Profile

Concord Medical Services Holding Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. It provides radiotherapy and diagnostic equipment leasing services to hospitals; and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals, It operates through Network Business and Hospital Business segments. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Head office	Cayman Islands
CEO	Jianyu Yang
Employees	595
Founded	2007
Website	www.concordmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now